Patent 7700652 was granted and assigned to Xenoport, Inc. on April, 2010 by the United States Patent and Trademark Office.
Disclosed herein are methods of using prodrugs of GABA analogs and pharmaceutical compositions thereof to treat and/or prevent urinary incontinence in humans, and pharmaceutical compositions of prodrugs of GABA analogs useful in treating and/or preventing urinary incontinence.